Direxion Daily S&P Biotech Bull 3X Shares (LABU) Dividend Yield, History & Forecast

Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund (ETF) listed on the New York Stock Exchange Arca. It pays a current dividend yield of 0.38% ($1.01 per share annually (TTM)). The most recent ex-dividend date was December 23, 2025, with payment scheduled for December 31, 2025. market capitalization is approximately $1.39B. Review LABU dividend history on this scorecard, compare peers in the Compare Dividend Returns tool, or project income with the dividend calculator.

LABU fund composition

LABU holds 156 positions, with 10.4% of assets in its ten largest. It charges an expense ratio of 0.96%, and manages $575.5M.

Top 10 holdings

HoldingWeight
MRNAMODERNA INC1.98%
TWSTTWIST BIOSCIENCE CORP1.17%
APGEAPOGEE THERAPEUTICS INC0.99%
HALOHALOZYME THERAPEUTICS INC0.94%
KYMRKYMERA THERAPEUTICS INC0.92%
NTRANATERA INC0.91%
PRAXPRAXIS PRECISION MEDICINES I0.90%
RVMDREVOLUTION MEDICINES INC0.88%
TVTXTRAVERE THERAPEUTICS INC0.87%
ORKAORUKA THERAPEUTICS INC0.86%

Sector allocation

Healthcare99.3%Cash & Others75.2%Financial Services0.7%Basic Materials0.0%

Frequently Asked Questions about Direxion Daily S&P Biotech Bull 3X Shares (LABU)

What is Direxion Daily S&P Biotech Bull 3X Shares's dividend yield?
Direxion Daily S&P Biotech Bull 3X Shares (LABU) pays a current trailing twelve-month dividend yield of 0.38%, which works out to $1.01 per share annually based on the most recent payout schedule.
When does Direxion Daily S&P Biotech Bull 3X Shares pay distributions?
The most recent ex-dividend date was December 23, 2025. The next scheduled dividend payment date is December 31, 2025.
How many years has Direxion Daily S&P Biotech Bull 3X Shares increased its dividend?
Direxion Daily S&P Biotech Bull 3X Shares (LABU) has increased its dividend for 1 consecutive year.
What does Direxion Daily S&P Biotech Bull 3X Shares invest in?
Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF is an exchange traded fund launched by Direxion Investments. It is managed by Rafferty Asset Management, LLC. It invests in public equity markets of the United States. It invests directly, through derivatives and through other funds in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. It uses derivatives such as futures, swaps to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track 3x...